About 6 results found for searched term "EZH2" (0.053 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2114 | GSK126 | EZH2 |
| EZH2 inhibitor; GSK2816126A | ||
| GSK126 is a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity. | ||
| M29185 | EZH2-IN-4 | Histone Methyltransferase |
| EZH2-IN-4 is an orally active, potent EZH2 inhibitor with IC50s of 0.923 nM and 2.65 nM against wild type (WT) 5-membered (5-mer) EZH2 and mutant 5-mer EZH2, respectively. EZH2-IN-4 has anti-cancer activity. | ||
| M29405 | EZH2-IN-2 | Histone Methyltransferase |
| EZH2-IN-2 is a EZH2 inhibitor, with an IC50 of 64 nM. EZH2-IN-2 can be used for the research of cancer or precancerous condition related to EZH2 activity. | ||
| M41699 | EZH2-IN-15 | Histone Methyltransferase |
| EZH2-IN-15 (SHR2554) is a EZH2 inhibitor. | ||
| M45107 | PARP/EZH2-IN-1 | PARP |
| PARP/EZH2-IN-1 is a first-in-class dual PARP (IC50 6.87 nM) and EZH2 (IC50 36.51 nM) inhibitor for triple-negative breast cancer with wild-type BRCA. | ||
| M53317 | SAH-EZH2 | Histone Methyltransferase |
| SAH-EZH2, a stable EZH2 α-helical peptide, is an EZH2/EED interaction inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
